Cancer is a rampant illness that has affected at least someone everybody knows. The conclusion is backed up by the National Cancer Institute whose data indicates that about 14.5 people in the United States suffered from cancer in 2014 alone. The studies’ estimation stated that the number would likely skyrocket to 19 million by 2024. The devastating statistics is the reason why revolutionary firms such as Tempus work diligently and strategically to alienate the suffering of affected persons dramatically and possibly find a cure.
Tempus is the foundation of entrepreneur Eric Lofkosfky, who is also the owner of Groupon. Eric had a painful personal experience with the illnesses when his wife was diagnosed with it. He was astounded at the lack of information and resources available to combat the illness and improve therapy for patients. He explained that innumerable researches had indicated the importance of using custom data to treat individual cases but few had managed to implement the theory.
Eric started Tempus to focus on the genome sequencing that would determine the best treatment plan for each person. They set up an analytics software that would save and accurately analyze medical data for every patient. The software uses natural language to present information, identify optical attributes, and translate conclusions in understandable formats and learn more about Eric.
The process of formulating a treatment plan from genome sequencing is old and has the earliest dating in 2003. It began at the price of $100 million and currently values at $5000. Tempus creation of a software that performs the same duty is set to reduce the price drastically and afford the procedure to the average American and more information click here.
Eric Lofkosfky was born in Southfield, Michigan and attended the University of Michigan where he graduated in 1991. He pursued a law degree from the same institution and graduated with a Juris doctor. Eric’s professionals talents are widespread, hence he heads several boards and sits as a member on others such as Lurie Memorial Hospital and the Art Institute of Chicago. He has taught as a professor at DePaul University and Northwestern University. Currently he teaches at the school of business of the University of Chicago.